Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Although it is unclear which cellular factor(s) is responsible for the genetic instability associated with initiating and sustaining cell transformation, it is known that many cancers have mutations that inactivate the Rb-mediated proliferation pathway. We show here that pRb inactivation and the resultant deregulation of one E2F family member, E2F1, leads to DNA double-strand break (DSB) accumulation in normal diploid human cells. These DSBs occur independent of Atm, p53, caspases, reactive oxygen species, and apoptosis. Moreover, E2F1 does not contribute to c-Myc-associated DSBs, indicating that the DSBs associated with these oncoproteins arise through distinct pathways. We also find E2F1-associated DSBs in an Rb mutated cancer cell line in the absence of an exogenous DSB stimulus. These basal, E2F1-associated DSBs are not observed in a p16(ink4a) inactivated cancer cell line that retains functional pRb, unless pRb is depleted. Thus, Rb status is key to regulating both the proliferation promoting functions associated with E2F and for preventing DNA damage accumulation if E2F1 becomes deregulated. Taken together, these data suggest that loss of Rb creates strong selective pressure, via DSB accumulation, for inactivating p53 mutations and that E2F1 contributes to the genetic instability associated with transformation and tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of INK4A (which is encoded by CDKN2A and is also known as p16) or expression of E1A is insufficient to disrupt RB inhibition of E2F1-dependent apoptosis92,94.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [94]
In the citing paper
“Both decreased INK4A and presence of E1A result in inhibition of protein interactions that are mediated through the RB pocket region, suggesting the structure and/or specific modifications of RB might distinctly regulate individual functions”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [94]
Citations
Cites
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 1×
“Indeed, recent data suggest that loss of DNA damage checkpoint control encourages the progression of cancer through different stages of tumorigenesis (Bartkova et al., 2005; Gorgoulis et al., 2005).”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098 · cited 1×
“In response to DSBs, H2AX is phosphorylated and localizes adjacent to the sites of the breaks (Rogakou et al., 1998; Paull et al., 2000).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
Nevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Distinct roles for E2F proteins in cell growth control and apoptosis
DeGregori, J., Leone, G., Miron, A., Jakoi, L., & Nevins, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7245 · Cited by 703
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610
Kowalik, T. F., DeGregori, J., Schwarz, J. K., & Nevins, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2491-2500.1995 · Cited by 418
Self-citationWhite, A. E., Livanos, E. M., & Tlsty, T. D. (1994) · Genes & Development · doi:10.1101/gad.8.6.666 · Cited by 368
Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R. G., & Kanakura, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00522-1 · Cited by 291
Myc Requires Distinct E2F Activities to Induce S Phase and Apoptosis
Leone, G., Sears, R., Huang, E., Rempel, R., Nuckolls, F., Park, C.-H., Giangrande, P., Wu, L., Saavedra, H. I., Field, S. J., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00275-1 · Cited by 268
E2F1 and c-Myc in Cell Growth and Death
Matsumura, I., Tanaka, H., & Kanakura, Y. (2003) · Cell Cycle · doi:10.4161/cc.2.4.428 · Cited by 172
Schwarz, J. K., Bassing, C. H., Kovesdi, I., Datto, M. B., Blazing, M., George, S., Wang, X. F., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.483 · Cited by 164
E2F1 Uses the ATM Signaling Pathway to Induce p53 and Chk2 Phosphorylation and Apoptosis
Powers, J. T., Hong, S., Mayhew, C. N., Rogers, P. M., Knudsen, E. S., & Johnson, D. G. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.203.2.4 · Cited by 152
ATM is a target for positive regulation by E2F-1
Berkovich, E., & Ginsberg, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206144 · Cited by 149
Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2
Rogoff, H. A., Pickering, M. T., Frame, F. M., Debatis, M. E., Sanchez, Y., Jones, S., & Kowalik, T. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2968-2977.2004 · Cited by 123
Self-citationRole of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
Tominaga, K., Morisaki, H., Kaneko, Y., Fujimoto, A., Tanaka, T., Ohtsubo, M., Hirai, M., Okayama, H., Ikeda, K., & Nakanishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31463 · Cited by 99
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult
Bosco, E. E. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkg919 · Cited by 97
Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry
Lomazzi, M., Moroni, M. C., Jensen, M. R., Frittoli, E., & Helin, K. (2002) · Nature Genetics · doi:10.1038/ng891 · Cited by 93
Biroccio, A., Benassi, B., Amodei, S., Gabellini, C., Bufalo, D. D., & Zupi, G. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.174 · Cited by 81
Cited by
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
“Aberrant activation of the Rb-E2F pathway leads to the formation of DNA double-strand breaks (DSBs) and chromosomal instability (Frame et al., 2006; Pickering and Kowalik, 2006).”
DNA damage signalling guards against activated oncogenes and tumour progression
Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521
“…tumour suppressor p16ink4a seem to be unable to activate the DDR machinery, gene knockout or inactivation of the retinoblastoma tumour suppressor (Pickering and Kowalik, 2006; Tort et al., 2006) and overexpression of several oncogenes in the RB pathway, such as E2F1 or cyclin E, did evoke the…”
BackgroundSynthetic lethal therapies for cancer: what’s next after PARP inhibitors?
Ashworth, A., & Lord, C. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0055-6 · Cited by 420
Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn024 · Cited by 351
Metadata
- Authors
- Pickering, M. T., & Kowalik, T. F.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Kowalik, T F
- Venue
- Oncogene
- Published
- 2005-09-26
- Volume
- 25
- Issue
- 5
- Pages
- 746-755
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2077755090
- Cited by
- 108
- References
- 25
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 6 · 2013: 6 · 2012: 10
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Cancer Institute (R01CA086038, CA-86038)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- retinoblastoma protein, Rb inactivation, E2F1, DNA double-strand breaks, genomic instability, cell transformation, p16INK4a, p53, c-Myc, DNA damage accumulation, carcinogenesis
- MeSH terms
- Base Sequence, Cell Transformation, Neoplastic, Cells, Cultured, DNA Damage, Humans, Genes, Retinoblastoma, Proto-Oncogene Proteins c-myc, RNA, Small Interfering, E2F1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.